Zdrowie i gospodarka · 26/07/2011

FDA Updates Labeling for Over-the-Counter Bronchodilators to Treat Asthma and Other Conditions

The US Food and Drug Administration (FDA) is updating the labeling for over-the-counter bronchodilator medications to include additional warnings and revised instructions for products containing certain ingredients, following data and feedback submitted by manufacturers. This change is part of the FDA's ongoing review of over-the-counter drug products.